Adaptive auto-regulation of androgen receptor provides a paradigm shifting rationale for bipolar androgen therapy (BAT) for castrate resistant human prostate cancer

Abiraterone and Increased Survival in Metastatic Prostate Cancer

(2011) Johann S. de Bono et al.   NEW ENGLAND JOURNAL OF MEDICINE

Androgen-induced TOP2B-mediated double-strand breaks and prostate cancer gene rearrangements

(2010) Michael C Haffner et al.   NATURE GENETICS

Loss of Androgen Receptor-Dependent Growth Suppression by Prostate Cancer Cells Can Occur Independently from Acquiring Oncogenic Addiction to Androgen Receptor Signaling

(2010) Jason M. D'Antonio et al.   PLoS One

DNA licensing as a novel androgen receptor mediated therapeutic target for prostate cancer

(2009) Jason M D'Antonio et al.   ENDOCRINE-RELATED CANCER

Copy number analysis indicates monoclonal origin of lethal metastatic prostate cancer

(2009) Wennuan Liu et al.   NATURE MEDICINE

Tissue culture media supplemented with 10% fetal calf serum contains a castrate level of testosterone

(2009) J.P. Michiel Sedelaar et al.   PROSTATE

Cell-autonomous intracellular androgen receptor signaling drives the growth of human prostate cancer initiating cells

(2009) Donald J. Vander Griend et al.   PROSTATE

Splicing of a Novel Androgen Receptor Exon Generates a Constitutively Active Androgen Receptor that Mediates Prostate Cancer Therapy Resistance

(2008) S. M. Dehm et al.   CANCER RESEARCH

The Role of CD133 in Normal Human Prostate Stem Cells and Malignant Cancer-Initiating Cells

(2008) D. J. Vander Griend et al.   CANCER RESEARCH

In vivo Knockdown of the Androgen Receptor Results in Growth Inhibition and Regression of Well-Established, Castration-Resistant Prostate Tumors

(2008) R. Snoek et al.   CLINICAL CANCER RESEARCH

Characterization of PacMetUT1, a recently isolated human prostate cancer cell line

(2008) D.A. Troyer et al.   PROSTATE